Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
暂无分享,去创建一个
J. Bourhis | N. Kröger | P. Chevallier | I. Yakoub-Agha | D. Blaise | A. Tomaszewska | C. Solano | D. Niederwieser | M. Ladetto | H. Greinix | C. Scheid | L. Castagna | G. Basak | B. Afanasyev | F. Ciceri | G. Socié | P. Reményi | N. Milpied | Z. Perić | A. Rambaldi | B. Bruno | P. Corradini | H. Schoemans | M. Jagasia | C. Koenecke | E. Kanfer | O. Penack | R. Duarte | E. Beohou | F. Kroschinsky | H. Sengeloev | S. van der Werf